These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 7002694

  • 1. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P, Tomasi AM, Masoni A, Finzi C.
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative trial of combined oxprenolol-chlorthalidone and a beta-blockader and diuretic separately in primary arterial hypertension].
    Luna RL, Faerchtein I, de Vasconcelos EM, Arslanian L, de La Nuez SB, Pereira WQ, Puppin S, Campos JC, Roque AF, Kastansky I.
    Arq Bras Cardiol; 1979 Oct; 33(4):311-20. PubMed ID: 398212
    [No Abstract] [Full Text] [Related]

  • 4. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV, Borghi C, Ambrosioni E.
    Clin Ther; 1984 Oct; 6(5):708-18. PubMed ID: 6383615
    [Abstract] [Full Text] [Related]

  • 5. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
    Muiesan G, Agabiti-Rosei E, Buoninconti R, Carotti A, Fariello R, Innocenti P, Toso M, Valori C, Motolese M.
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
    [Abstract] [Full Text] [Related]

  • 6. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN.
    Int J Clin Pharmacol Res; 1983 Jun; 3(3):153-6. PubMed ID: 6679518
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M, Agabiti-Rosei E, Carotti A, Innocenti P, Montervino C, Solinas E, Toso M, Muiesan G.
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(8):332-7. PubMed ID: 7409934
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
    Masoni A, Tomasi AM, Pirani R, Lazzaretto R, Ambroso G.
    G Ital Cardiol; 1981 Jun; 11(12):2105-9. PubMed ID: 7346306
    [Abstract] [Full Text] [Related]

  • 10. [Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
    Cybulska I, Sznajderman M.
    Pol Tyg Lek; 1984 Apr 09; 39(15):501-3. PubMed ID: 6384962
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M, Cumetti C, Vergani A, Montanari C, De Cristofaro A.
    Drugs Exp Clin Res; 1985 Apr 09; 11(12):851-60. PubMed ID: 2873012
    [Abstract] [Full Text] [Related]

  • 13. Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study.
    Obel AO.
    J Cardiovasc Pharmacol; 1989 Mar 09; 13(3):465-70. PubMed ID: 2471894
    [Abstract] [Full Text] [Related]

  • 14. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
    Boike SC, Durley Y, Cubberley RB.
    Clin Pharm; 1982 Mar 09; 1(5):449-53. PubMed ID: 6764166
    [No Abstract] [Full Text] [Related]

  • 15. [Ergometric studies for supplementary evaluation of antihypertensive therapy].
    Franz IW, Lohmann FW.
    Verh Dtsch Ges Inn Med; 1982 Mar 09; 83():325-7. PubMed ID: 347807
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B, Wendt G.
    Med Welt; 1983 Sep 02; 34(35):941-4. PubMed ID: 6355745
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
    Bertoni T, Alberti D, Peloso A, Francucci BM, De Ambroggi L.
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar 02; 26(3):148-52. PubMed ID: 2970442
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.